Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2850 of 3546 entries
View as:

Open-label Study of Belimumab Plus Standard Therapy in Chinese Pediatric Participants With Active Systemic Lupus Erythematosus (SLE)

Phase: N/A Priority: Normal
NCT ID: NCT04908865 Org: User:
Start: 10/21/21 End: 08/13/24 Due: 08/13/25

SERETIDE Plus Tiotropium Versus Individual Components

Phase: N/A Priority: Normal
NCT ID: NCT00325169 Org: User:
Start: 12/31/05 End: 08/31/06 Due: 08/31/07

A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00281632 Org: User:
Start: 03/31/06 End: 10/31/10 Due: 10/31/11

Efficacy and Safety Study of GSK1120212, a MEK Inhibitor, in Subjects With Uveal Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01328106 Org: User:
Start: 11/30/10 End: 05/31/12 Due: 05/31/13

Study to Identify and Characterize the Bacteria Causing Acute Otitis Media Episodes in Young Children in Saudi Arabia

Phase: N/A Priority: Normal
NCT ID: NCT01204385 Org: User:
Start: 06/30/09 End: 05/31/11 Due: 05/31/12

Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00381238 Org: User:
Start: 06/20/06 End: 02/03/09 Due: 02/03/10

Safety and Immunogenicity of H1N1 Vaccines in Children Aged 6 Months to Less Than 9 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT00976820 Org: User:
Start: 10/20/09 End: 03/21/11 Due: 03/21/12

Immunogenicity and Safety of GlaxoSmithKline Biologicals' Huma Papillomavirus (HPV) Vaccine 580299 in Healthy Females 15 - 25 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT00552279 Org: User:
Start: 11/12/07 End: 07/20/09 Due: 07/20/10

Flixonase Safety in Patients With Allergic Rhinitis (AR)

Phase: N/A Priority: Normal
NCT ID: NCT01077609 Org: User:
Start: 01/31/08 End: 04/30/10 Due: 04/30/11

Evaluation of Safety of GlaxoSmithKline (GSK) Vaccines' Quadrivalent Seasonal Influenza Vaccine, Fluarix Tetra When Administered According to the Approved Prescribing Information (PI) in Korea.

Phase: N/A Priority: Normal
NCT ID: NCT02663102 Org: User:
Start: 10/20/16 End: 02/05/21 Due: 02/05/22

A First Time in Human Study in Healthy Male Volunteers for Compound GSK557296.

Phase: N/A Priority: Normal
NCT ID: NCT00549211 Org: User:
Start: 10/31/07 End: - Due: -

Study to Evaluate Immunological Equivalence Between Two Investigational Influenza Vaccines in Adults (H1N1)

Phase: N/A Priority: Normal
NCT ID: NCT00979407 Org: User:
Start: 10/12/09 End: 11/04/10 Due: 11/04/11

Schizophrenia Study In Adults

Phase: N/A Priority: Normal
NCT ID: NCT00049946 Org: User:
Start: 10/31/02 End: 04/30/03 Due: 04/30/04

Comparative Bioavailability of Two Fixed Dose Combination (FDC) Formulations of Dutasteride and Tamsulosin Hydrochloride Relative to Co-administration of Dutasteride With Tamsulosin Hydrochloride in Healthy Male Subjects Under Fed and Fasted States

Phase: N/A Priority: Normal
NCT ID: NCT02184585 Org: User:
Start: 07/10/14 End: 02/23/15 Due: 02/23/16

Immunogenicity and Safety of Meningococcal Vaccine GSK 134612 Versus Mencevax™ ACWY in Healthy 18-25 Year Olds

Phase: N/A Priority: Normal
NCT ID: NCT01154088 Org: User:
Start: 08/27/10 End: 12/30/10 Due: 12/30/11

Assess the Safety & Reactogenicity of DTPa-IPV/Hib Vaccine Administered at 3, 4, 5 & 18 Mths of Age, in Healthy Infants

Phase: N/A Priority: Normal
NCT ID: NCT00325156 Org: User:
Start: 11/02/04 End: 08/23/07 Due: 08/23/08

Systematic Review: Retigabine for Adjunctive Therapy in Partial Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT01587339 Org: User:
Start: 09/30/10 End: 07/31/11 Due: 07/31/12

Safety, Clinical Activity, Pharmacokinetics (PK) and Pharmacodynamics Study of GSK2879552, Alone or With Azacitidine, in Subjects With High Risk Myelodysplastic Syndromes (MDS)

Phase: N/A Priority: Normal
NCT ID: NCT02929498 Org: User:
Start: 07/31/17 End: 01/31/18 Due: 01/31/19

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02301975 Org: User:
Start: 03/01/15 End: 11/25/16 Due: 11/25/17

Evaluate Protective Efficacy of Diff Strengths of Human Rotavirus Vaccine After Admn of 2 Doses to Infants Aged 2 Months

Phase: N/A Priority: Normal
NCT ID: NCT00385320 Org: User:
Start: 05/31/01 End: 04/30/03 Due: 04/30/04

A Study to Assess the Safety of Single Doses of GSK189075 in Subjects With Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00575159 Org: User:
Start: 03/31/08 End: 12/18/08 Due: 12/18/09

A Three-Part Study Of GSK580416 In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00427141 Org: User:
Start: 10/31/06 End: - Due: -

Comparison Of Rituximab Versus Tositumomab and Iodine I 131 Tositumomab (BEXXAR® Therapeutic Regimen) For Patients With Relapsed Follicular Non-Hodgkins Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00268983 Org: User:
Start: 10/31/04 End: 06/30/13 Due: 06/30/14

Pharmacokinetic Profiles Of Amoxicillin 2000 mg And Clavulanate 125 mg In Adolescent Patients

Phase: N/A Priority: Normal
NCT ID: NCT00354965 Org: User:
Start: 01/19/06 End: 04/02/07 Due: 04/02/08

Randomized Study Evaluating the Effect of Danirixin on Neutrophil Extracellular Traps (NETs) in Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT03250689 Org: User:
Start: 11/15/17 End: 10/08/18 Due: 10/08/19